Eric E. Gardner

3.3k total citations · 1 hit paper
29 papers, 1.9k citations indexed

About

Eric E. Gardner is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Eric E. Gardner has authored 29 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 13 papers in Oncology and 7 papers in Cancer Research. Recurrent topics in Eric E. Gardner's work include Lung Cancer Research Studies (12 papers), RNA modifications and cancer (6 papers) and Cancer Genomics and Diagnostics (5 papers). Eric E. Gardner is often cited by papers focused on Lung Cancer Research Studies (12 papers), RNA modifications and cancer (6 papers) and Cancer Genomics and Diagnostics (5 papers). Eric E. Gardner collaborates with scholars based in United States, Israel and United Kingdom. Eric E. Gardner's co-authors include Charles M. Rudin, John T. Poirier, Elisa de Stanchina, Valentina E. Schneeberger, Patrice Desmeules, Ai Ni, Natasha Rekhtman, Benjamin H. Lok, Christine L. Hann and Lisa Sevenich and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Eric E. Gardner

27 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Macrophage Ontogeny Underlies Differences in Tumor-Specific Education in Brain Malignancies

2016 430 citations Robert L. Bowman, Florian Klemm et al. Cell Reports profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eric E. Gardner United States	17	989	904	411	358	224	29	1.9k
Gregory K. Friedman United States	27	815 0.8×	804 0.9×	316 0.8×	371 1.0×	174 0.8×	99	2.0k
Younghee Lee United States	23	1.0k 1.1×	629 0.7×	518 1.3×	118 0.3×	258 1.2×	93	2.4k
Rupert Ecker Austria	22	364 0.4×	793 0.9×	321 0.8×	269 0.8×	198 0.9×	35	2.0k
Asaf Madi Israel	27	658 0.7×	880 1.0×	1.5k 3.5×	151 0.4×	102 0.5×	42	2.8k
Akanksha Verma United States	25	950 1.0×	554 0.6×	353 0.9×	217 0.6×	132 0.6×	71	1.9k
Monique Verhaegen United States	24	1.6k 1.6×	1.2k 1.4×	211 0.5×	330 0.9×	96 0.4×	45	2.8k
Pengfei Yu China	22	1.2k 1.2×	663 0.7×	545 1.3×	150 0.4×	237 1.1×	79	2.4k
Yong Wan China	30	1.7k 1.8×	439 0.5×	252 0.6×	116 0.3×	180 0.8×	74	2.6k
Lisa M. Ebert Australia	29	644 0.7×	950 1.1×	1.4k 3.5×	116 0.3×	94 0.4×	54	2.4k
Nemanja D. Marjanovic United States	8	2.1k 2.1×	1.0k 1.2×	474 1.2×	137 0.4×	275 1.2×	12	3.0k

Countries citing papers authored by Eric E. Gardner

Since Specialization

Citations

This map shows the geographic impact of Eric E. Gardner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric E. Gardner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric E. Gardner more than expected).

Fields of papers citing papers by Eric E. Gardner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric E. Gardner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric E. Gardner. The network helps show where Eric E. Gardner may publish in the future.

Co-authorship network of co-authors of Eric E. Gardner

This figure shows the co-authorship network connecting the top 25 collaborators of Eric E. Gardner. A scholar is included among the top collaborators of Eric E. Gardner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric E. Gardner. Eric E. Gardner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Xiaoling, Eric E. Gardner, Sonia Molina‐Pinelo, et al.. (2025). Lineage plasticity and histological transformation: tumor histology as a spectrum. Cell Research. 35(11). 803–823. 1 indexed citations

Chen, Huanhuan Joyce, Eric E. Gardner, Yajas Shah, et al.. (2025). Metastatic small cell lung cancer arises from TP53/RB1-deficient and MYC overproduction hESC-derived PNECs. eLife. 13.

Gardner, Eric E., Ethan M. Earlie, Melissa J. Hubisz, et al.. (2024). Lineage-specific intolerance to oncogenic drivers restricts histological transformation. Science. 383(6683). eadj1415–eadj1415. 46 indexed citations

Chen, Huanhuan Joyce, Eric E. Gardner, Yajas Shah, et al.. (2024). Metastatic small cell lung cancer arises from TP53/RB1-deficient and MYC overproduction hESC-derived PNECs. eLife. 13.

Stein, Benjamin D., Eric E. Gardner, Jae Won Chang, et al.. (2023). LKB1-Dependent Regulation of TPI1 Creates a Divergent Metabolic Liability between Human and Mouse Lung Adenocarcinoma. Cancer Discovery. 13(4). 1002–1025. 20 indexed citations

Katti, Alyna, Miguel Foronda, J. Lynn Zimmerman, et al.. (2023). Generation of precision preclinical cancer models using regulated in vivo base editing. Nature Biotechnology. 42(3). 437–447. 21 indexed citations

Kern, Jeffrey A., Jihye Kim, Daniel G. Foster, et al.. (2020). Role of mTOR As an Essential Kinase in SCLC. Journal of Thoracic Oncology. 15(9). 1522–1534. 16 indexed citations

Gardner, Eric E., Benjamin H. Lok, Valentina E. Schneeberger, et al.. (2017). Chemosensitive Relapse in Small Cell Lung Cancer Proceeds through an EZH2-SLFN11 Axis. Cancer Cell. 31(2). 286–299. 347 indexed citations

Miles, Linde A., Laura N. Burga, Eric E. Gardner, et al.. (2017). Anthrax toxin receptor 1 is the cellular receptor for Seneca Valley virus. Journal of Clinical Investigation. 127(8). 2957–2967. 60 indexed citations

10.

Lok, Benjamin H., Eric E. Gardner, Valentina E. Schneeberger, et al.. (2016). PARP Inhibitor Activity Correlates with SLFN11 Expression and Demonstrates Synergy with Temozolomide in Small Cell Lung Cancer. Clinical Cancer Research. 23(2). 523–535. 261 indexed citations

11.

Schneeberger, Valentina E., Viola Allaj, Eric E. Gardner, John T. Poirier, & Charles M. Rudin. (2016). Quantitation of Murine Stroma and Selective Purification of the Human Tumor Component of Patient-Derived Xenografts for Genomic Analysis. PLoS ONE. 11(9). e0160587–e0160587. 41 indexed citations

12.

Bowman, Robert L., Florian Klemm, Leila Akkari, et al.. (2016). Macrophage Ontogeny Underlies Differences in Tumor-Specific Education in Brain Malignancies. Cell Reports. 17(9). 2445–2459. 430 indexed citations breakdown →

13.

Gardner, Eric E. & Charles M. Rudin. (2015). Preclinical oncology — reporting transparency needed. Nature Reviews Clinical Oncology. 13(1). 8–9. 1 indexed citations

14.

Poirier, John T., Eric E. Gardner, Nick Connis, et al.. (2015). DNA methylation in small cell lung cancer defines distinct disease subtypes and correlates with high expression of EZH2. Oncogene. 34(48). 5869–5878. 166 indexed citations

15.

Gardner, Eric E., Nick Connis, John T. Poirier, et al.. (2014). Rapamycin Rescues ABT-737 Efficacy in Small Cell Lung Cancer. Cancer Research. 74(10). 2846–2856. 45 indexed citations

16.

Zinn, Rebekah L., Eric E. Gardner, Luigi Marchionni, et al.. (2013). ERK Phosphorylation Is Predictive of Resistance to IGF-1R Inhibition in Small Cell Lung Cancer. Molecular Cancer Therapeutics. 12(6). 1131–1139. 33 indexed citations

17.

Zinn, Rebekah L., Eric E. Gardner, Irina Dobromilskaya, et al.. (2013). Combination treatment with ABT-737 and chloroquine in preclinical models of small cell lung cancer. Molecular Cancer. 12(1). 16–16. 45 indexed citations

18.

Yanamala, Naveena, et al.. (2011). The Cytoplasmic Rhodopsin-Protein Interface: Potential for Drug Discovery. Current Drug Targets. 13(1). 3–14. 4 indexed citations

19.

Gardner, Eric E., et al.. (2008). Differential coupling of the human cannabinoid receptors hCB1R and hCB2R to the G-protein Gαi2β1γ2. Neuroscience Letters. 447(1). 68–72. 11 indexed citations

20.

Kwok, John B., Eric E. Gardner, Jon Warner, B A Ponder, & Lois M. Mulligan. (1993). Structural analysis of the human ret proto-oncogene using exon trapping.. PubMed. 8(9). 2575–82. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact